India  

Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programme

IndiaTimes Friday, 23 July 2021
Bharat Biotech on Friday said it has committed to supply over 500 million doses of its COVID-19 vaccine Covaxin to the Centre under the countrywide immunisation programme.
0
shares
ShareTweetSavePostSend
 

πŸ’‘ newsR Knowledge: Other News Mentions

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Month after month, Covaxin missing production target

Homegrown Covaxin was to play a major role in vaccination against Covid-19. But eight months after the vaccination drive began, only one in 11 Indians has..
IndiaTimes

Covaxin supply to hit 5.5 cr doses from October: Bharat Biotech chairman

Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr..
IndiaTimes

Covaxin Covaxin Vaccine against COVID-19

Covaxin yet to receive WHO's emergency use clearance over technical queries: Report

The countries that have approved Covaxin include Iran, the Philippines, Mauritius, Mexico, Nepal, Guyana, Paraguay, and Zimbabwe.
DNA
Mixing vaccines study gets DCGI nod | Are 2 different vaccines better than 1? | Oneindia News [Video]

Mixing vaccines study gets DCGI nod | Are 2 different vaccines better than 1? | Oneindia News

A study on mixing Covishield and Covaxin has been given the go ahead by the drug regulator--Drug Controller General of India. This study and its clinical trials will be conducted by Vellore's Christian Medical College. #MixingVaccines #VaccineCocktail #ICMR

Credit: Oneindia    Duration: 01:46Published

You Might Like


Related videos from verified sources

Raab: UK wants world vaccinated by 2022 [Video]

Raab: UK wants world vaccinated by 2022

Foreign Secretary Dominic Raab has said the UK wants the world vaccinated against Covid-19 by 2022.Britain is donating nine million doses of the AstraZeneca coronavirus vaccine to countries including..

Credit: PA - Press Association STUDIO     Duration: 00:52Published
ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 | Oneindia News [Video]

ISRO plans to launch satellite GISAT-1 on board a GSLV-F10 rocket on August 12 | Oneindia News

The Indian Space Research Organisation is getting back into launch activity at Sriharikota spaceport; Today in the afternoon, three militants were killed in an encounter with security forces in..

Credit: Oneindia     Duration: 02:35Published
Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News [Video]

Covaxin is 77.8% effective against Covid-19, claims Bharat Biotech: Details | Oneindia News

Covaxin maker Bharat Biotech has claimed that the vaccine is 77.8% effective overall against Covid-19 after analysing results for its phase 3 trials. Bharat Biotech also claimed that Covaxin provides..

Credit: Oneindia     Duration: 02:13Published

Related news from verified sources

Probe Covaxin deal with Brazil: Congress

Congress on Friday demanded that Prime Minister Narendra Modi order an inquiry into the Covaxin deal with Brazil as it focussed on the probe ordered in the...
IndiaTimes

Covaxin has overall vaccine efficacy of 77.8%, claims Bharat Biotech in results from Phase 3 trials

Covaxin showed 65.2% protection against the Delta variant (B.1.617.2) of COVID-19.Β 
Zee News

WHO Chief Scientist Dr Swaminathan says phase-3 trials of Covaxin look good, Bharat Biotech awaits approval

A few days ago, Bharat Biotech had released the phase 3 clinical trial results of Covaxin after evaluating 130 symptomatic COVID-19 cases.
DNA